$HQL insiders have traded $HQL stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales. Here’s a ...
abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL’s income-focused strategy relies on net realized gains, supporting ...
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, ...
Tekla Life Sciences Investors is a closed-ended equity fund that primarily invests in the life sciences sector, with a heavy focus on biotech and pharmaceuticals. The fund's dividend history has been ...
Get complete details on the Abrdn Life Sciences Investors stock dividend, including HQL dividend history and HQL dividend yield. Find the latest HQL dividend date, ex-dividend date, and dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results